Tandem Diabetes Care (TNDM)
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally.
If you are interested in TNDM stock information, you might also be interested in competitors like NasdaqGS:DXCM.
With a P/E ratio of 0.00, the stock appears relatively cheap compared to its index ^SPX at the moment.
The market capitalization of Tandem Diabetes Care is currently at $3.82 B. This places it among the medium capitalized companies.
The book value reported in the balance sheet results in a P/B ratio of 8.51.
With one share of Tandem Diabetes Care investors achieved a dividend of $0.00. This results in a very low dividend yield of 0.00%.
For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.78. The price of the stock NasdaqGM:TNDM is therefore subject to moderate fluctuations in relation to the overall market.
0.57% of TNDM Stocks is owned by insiders.
For Wall Street analysts, a price target of $127.93 is currently considered realistic.
NasdaqGM:TNDM has a 52 week range of $52.08 - $155.86 and is currently trading around $59.54.
The low short sale ratio indicated that the value might increase in the foreseeable future.